Boston Scientific Recalls HOT AXIOS Stent and Delivery System Over Deployment Failures
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Boston Scientific has issued a Class I recall for 266 units of the HOT AXIOS Stent and Delivery System due to reports of deployment and expansion issues that may require surgical intervention.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references Worldwide. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Boston Scientific Corporation has initiated a voluntary recall of the HOT AXIOS Stent and Electrocautery-Enhanced Delivery System. The recall follows an increase in reports regarding stent deployment and expansion difficulties. According to the FDA, the most common foreseeable outcome is a prolongation of the medical procedure to exchange the faulty device for a new one. However, more serious cases where the first flange fails to deploy or expand can lead to a cascade of events requiring additional endoscopic or surgical intervention to remove the stent and close the puncture site.
Which Products Are Affected
The recall specifically involves the HOT AXIOS Stent and Electrocautery-Enhanced Delivery System (6mm x 8mm).
- Material Number (UPN): M00553520
- UDI-DI: 8714729904540
- Recall Number: Z-1161-2026
- Quantity: 266 units
- Lot Numbers: The recall affects over 200 specific lots, including 36067957, 36067958, 36067959, 36067960, 36067961, 36099410, 36102139, 36111317, 36111318, 36111319, and many others listed in the official FDA enforcement report.
The distribution of these devices is worldwide, including nationwide distribution in the United States and Puerto Rico, as well as over 50 other countries across Europe, Asia, the Middle East, and the Americas.
What You Should Do
This is a firm-initiated voluntary recall. Healthcare facilities and providers in possession of the affected lots should immediately stop using the devices and follow the instructions provided by Boston Scientific Corporation for the return or exchange of the product. For further inquiries, the recalling firm is located at 100 Boston Scientific Way, Marlborough, MA 01752.
Why This Matters
This recall has been designated as Class I, the most serious classification. Failure of the stent to deploy or expand correctly during a procedure can lead to significant medical complications, potentially requiring invasive surgery to repair puncture sites or remove the malfunctioning device.
Source
Information provided by the FDA.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.